Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

749 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs

NCT04047680

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +16 more
Locations: National Taiwan University Hospital, Yun-Lin Branch Douliu, Taiwan

National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Implementation and Evaluation of Care Coordination in Linkage to Care for Hepatitis C Following Release From New York City Jails

NCT04036760

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: NYU Langone Health New York, United States

View Trial Details

Completed

Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)

NCT02332720

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar

NCT03579576

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +20 more
Locations: Waimaw Kāchen, Kachin State, Burma

Myanmar Liver Foundation Clinic Mandalay, Burma

Myanmar Liver Foundation Charity Clinic Yangon, Burma

View Trial Details

Completed

Evaluation Study of RDTs Detecting Antibodies Against HCV

NCT04033887

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +20 more
Locations: Institute of Tropical Medicine Antwerp, Belgium

National Center for Disease Control & Public Health/Lugar Center Tbilisi, Georgia

Nigerian Institute of Medical Research Lagos, Nigeria

View Trial Details

Completed

Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)

NCT02332707

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers

NCT03038763

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot Study

NCT03231930

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +11 more
Locations: Innerspace Collingwood, Victoria, Australia

Health Works Footscray, Victoria, Australia

North Richmond Community Health Richmond, Victoria, Australia

View Trial Details

Completed

Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV

NCT02600325

Conditions: Acquired Immunodeficiency Syndrome, Acute Hepatitis C, Blood-Borne Infections, +21 more
Locations: Institute of Tropical Medicine Antwerp (ITG) Antwerp, Belgium

Erasmus Medical Center (EMC) Rotterdam, South Holland, Netherlands

Onze Lieve Vrouwe Gasthuis (OLVG) Amsterdam, Netherlands

Slotervaart Hospital Amsterdam, Netherlands

View Trial Details

Completed

The Boceprevir and Sildenafil Pharmacokinetics Study

NCT01499498

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Imperial College Healthcare NHS Trust London, United Kingdom

View Trial Details

Hepatitis C

Hepatitis C trial results

Related conditions